⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL170596 | 0.73 | — | — | |
| SCHEMBL303281 | 0.72 | — | — | |
| SCHEMBL5250874 | 0.70 | — | — | |
| SCHEMBL12274522 | 0.69 | — | — | |
| SCHEMBL14955465 | 0.69 | — | — | |
| SCHEMBL1425619 | 0.68 | — | — | |
| SCHEMBL169332 | 0.67 | — | — | |
| SCHEMBL982269 | 0.66 | — | — | |
| SCHEMBL9274761 | 0.65 | RNPEP (0.32) | — | |
| SCHEMBL7170673 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100113411-A1 | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2010-05-06 | — | — | US | claimed |
| EP-1558600-B1 | SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT | BOEHRINGER INGELHEIM PHARMA (DE) | 2008-05-07 | — | — | EP | claimed |
| US-20060079504-A1 | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) | 2006-04-13 | — | — | US | claimed |
| US-5147882-A | Cardiovascular disorders | KARL THOMAE GMBH (DE) | 1992-09-15 | — | — | US | claimed |
| US-20100113411-A1 | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2010-05-06 | — | — | US | disclosed |
| US-7595312-B2 | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2009-09-29 | — | — | US | disclosed |
| US-20060079504-A1 | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) | 2006-04-13 | — | — | US | disclosed |
| EP-0986376-A1 | COMPOSITIONS FOR TREATING AND PREVENTING ARTERIAL THROMBOSIS AND USE OF A FACTOR Xa INHIBITOR ON ITS OWN AND/OR COMBINED WITH A PLATELET ANTIAGGREGATING AGENT | SANOFI-SYNTHELABO (FR) | 2000-03-22 | — | — | EP | disclosed |
| WO-1998056365-A1 | COMPOSITIONS FOR TREATING AND PREVENTING ARTERIAL THROMBOSIS AND USE OF A FACTOR Xa INHIBITOR ON ITS OWN AND/OR COMBINED WITH A PLATELET ANTIAGGREGATING AGENT | SANOFI-SYNTHELABO (FR) | 1998-12-17 | — | — | WO | disclosed |
| US-5591769-A | PYRROLIDINE DERIVATIVES; ANTICOAGULANTS | KARL THOMAE GMBH (DE) | 1997-01-07 | — | — | US | disclosed |
| US-5489693-A | ANTICOAGULANTS | DR. KARK THOMAE, GMBH (DE) | 1996-02-06 | — | — | US | disclosed |
| US-5147882-A | Cardiovascular disorders | KARL THOMAE GMBH (DE) | 1992-09-15 | — | — | US | disclosed |